Report Detail
Global Gene Therapy for Sickle Cell Disease Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4736697 |
- 24 August, 2026 |
- Global |
- 99 Pages |
- GIR |
- Other
According to our (Global Info Research) latest study, the global Gene Therapy for Sickle Cell Disease market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Gene therapy for sickle cell disease is a treatment that aims to correct the genetic mutation responsible for producing abnormal hemoglobin, which leads to sickle-shaped red blood cells. This process involves extracting the patient's hematopoietic stem cells, introducing a functional copy of the β-globin gene to restore normal hemoglobin production, and reinfusing the modified cells back into the patient.The goal is to alleviate symptoms and complications of the disease, such as pain crises and anemia, potentially offering a long-term cure for affected individuals.
This report is a detailed and comprehensive analysis for global Gene Therapy for Sickle Cell Disease market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Gene Therapy for Sickle Cell Disease market size and forecasts, in consumption value ($ Million), 2021-2032
Global Gene Therapy for Sickle Cell Disease market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Gene Therapy for Sickle Cell Disease market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Gene Therapy for Sickle Cell Disease market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene Therapy for Sickle Cell Disease
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene Therapy for Sickle Cell Disease market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vertex Pharmaceuticals, Bluebird bio, Editas Medicine, CRISPR Therapeutics, Beam Therapeutics, Intellia Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Gene Therapy for Sickle Cell Disease market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Gene Addition Therapies
Gene Editing Therapies
Others
Market segment by Application
Children and Adolescents
Adults
Market segment by players, this report covers
Vertex Pharmaceuticals
Bluebird bio
Editas Medicine
CRISPR Therapeutics
Beam Therapeutics
Intellia Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Therapy for Sickle Cell Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Therapy for Sickle Cell Disease, with revenue, gross margin, and global market share of Gene Therapy for Sickle Cell Disease from 2021 to 2026.
Chapter 3, the Gene Therapy for Sickle Cell Disease competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Gene Therapy for Sickle Cell Disease market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapy for Sickle Cell Disease.
Chapter 13, to describe Gene Therapy for Sickle Cell Disease research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Gene Therapy for Sickle Cell Disease by Type
- 1.3.1 Overview: Global Gene Therapy for Sickle Cell Disease Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Gene Therapy for Sickle Cell Disease Consumption Value Market Share by Type in 2025
- 1.3.3 Gene Addition Therapies
- 1.3.4 Gene Editing Therapies
- 1.3.5 Others
- 1.4 Global Gene Therapy for Sickle Cell Disease Market by Application
- 1.4.1 Overview: Global Gene Therapy for Sickle Cell Disease Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Children and Adolescents
- 1.4.3 Adults
- 1.5 Global Gene Therapy for Sickle Cell Disease Market Size & Forecast
- 1.6 Global Gene Therapy for Sickle Cell Disease Market Size and Forecast by Region
- 1.6.1 Global Gene Therapy for Sickle Cell Disease Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Gene Therapy for Sickle Cell Disease Market Size by Region, (2021-2032)
- 1.6.3 North America Gene Therapy for Sickle Cell Disease Market Size and Prospect (2021-2032)
- 1.6.4 Europe Gene Therapy for Sickle Cell Disease Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Gene Therapy for Sickle Cell Disease Market Size and Prospect (2021-2032)
- 1.6.6 South America Gene Therapy for Sickle Cell Disease Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Gene Therapy for Sickle Cell Disease Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Vertex Pharmaceuticals
- 2.1.1 Vertex Pharmaceuticals Details
- 2.1.2 Vertex Pharmaceuticals Major Business
- 2.1.3 Vertex Pharmaceuticals Gene Therapy for Sickle Cell Disease Product and Solutions
- 2.1.4 Vertex Pharmaceuticals Gene Therapy for Sickle Cell Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Vertex Pharmaceuticals Recent Developments and Future Plans
- 2.2 Bluebird bio
- 2.2.1 Bluebird bio Details
- 2.2.2 Bluebird bio Major Business
- 2.2.3 Bluebird bio Gene Therapy for Sickle Cell Disease Product and Solutions
- 2.2.4 Bluebird bio Gene Therapy for Sickle Cell Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Bluebird bio Recent Developments and Future Plans
- 2.3 Editas Medicine
- 2.3.1 Editas Medicine Details
- 2.3.2 Editas Medicine Major Business
- 2.3.3 Editas Medicine Gene Therapy for Sickle Cell Disease Product and Solutions
- 2.3.4 Editas Medicine Gene Therapy for Sickle Cell Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Editas Medicine Recent Developments and Future Plans
- 2.4 CRISPR Therapeutics
- 2.4.1 CRISPR Therapeutics Details
- 2.4.2 CRISPR Therapeutics Major Business
- 2.4.3 CRISPR Therapeutics Gene Therapy for Sickle Cell Disease Product and Solutions
- 2.4.4 CRISPR Therapeutics Gene Therapy for Sickle Cell Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 CRISPR Therapeutics Recent Developments and Future Plans
- 2.5 Beam Therapeutics
- 2.5.1 Beam Therapeutics Details
- 2.5.2 Beam Therapeutics Major Business
- 2.5.3 Beam Therapeutics Gene Therapy for Sickle Cell Disease Product and Solutions
- 2.5.4 Beam Therapeutics Gene Therapy for Sickle Cell Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Beam Therapeutics Recent Developments and Future Plans
- 2.6 Intellia Therapeutics
- 2.6.1 Intellia Therapeutics Details
- 2.6.2 Intellia Therapeutics Major Business
- 2.6.3 Intellia Therapeutics Gene Therapy for Sickle Cell Disease Product and Solutions
- 2.6.4 Intellia Therapeutics Gene Therapy for Sickle Cell Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Intellia Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Gene Therapy for Sickle Cell Disease Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Gene Therapy for Sickle Cell Disease by Company Revenue
- 3.2.2 Top 3 Gene Therapy for Sickle Cell Disease Players Market Share in 2025
- 3.2.3 Top 6 Gene Therapy for Sickle Cell Disease Players Market Share in 2025
- 3.3 Gene Therapy for Sickle Cell Disease Market: Overall Company Footprint Analysis
- 3.3.1 Gene Therapy for Sickle Cell Disease Market: Region Footprint
- 3.3.2 Gene Therapy for Sickle Cell Disease Market: Company Product Type Footprint
- 3.3.3 Gene Therapy for Sickle Cell Disease Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Gene Therapy for Sickle Cell Disease Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Gene Therapy for Sickle Cell Disease Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Gene Therapy for Sickle Cell Disease Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Gene Therapy for Sickle Cell Disease Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Gene Therapy for Sickle Cell Disease Consumption Value by Type (2021-2032)
- 6.2 North America Gene Therapy for Sickle Cell Disease Market Size by Application (2021-2032)
- 6.3 North America Gene Therapy for Sickle Cell Disease Market Size by Country
- 6.3.1 North America Gene Therapy for Sickle Cell Disease Consumption Value by Country (2021-2032)
- 6.3.2 United States Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
- 6.3.3 Canada Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Gene Therapy for Sickle Cell Disease Consumption Value by Type (2021-2032)
- 7.2 Europe Gene Therapy for Sickle Cell Disease Consumption Value by Application (2021-2032)
- 7.3 Europe Gene Therapy for Sickle Cell Disease Market Size by Country
- 7.3.1 Europe Gene Therapy for Sickle Cell Disease Consumption Value by Country (2021-2032)
- 7.3.2 Germany Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
- 7.3.3 France Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
- 7.3.5 Russia Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
- 7.3.6 Italy Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Gene Therapy for Sickle Cell Disease Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Gene Therapy for Sickle Cell Disease Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Gene Therapy for Sickle Cell Disease Market Size by Region
- 8.3.1 Asia-Pacific Gene Therapy for Sickle Cell Disease Consumption Value by Region (2021-2032)
- 8.3.2 China Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
- 8.3.3 Japan Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
- 8.3.5 India Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
- 8.3.7 Australia Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Gene Therapy for Sickle Cell Disease Consumption Value by Type (2021-2032)
- 9.2 South America Gene Therapy for Sickle Cell Disease Consumption Value by Application (2021-2032)
- 9.3 South America Gene Therapy for Sickle Cell Disease Market Size by Country
- 9.3.1 South America Gene Therapy for Sickle Cell Disease Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Gene Therapy for Sickle Cell Disease Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Gene Therapy for Sickle Cell Disease Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Gene Therapy for Sickle Cell Disease Market Size by Country
- 10.3.1 Middle East & Africa Gene Therapy for Sickle Cell Disease Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
- 10.3.4 UAE Gene Therapy for Sickle Cell Disease Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Gene Therapy for Sickle Cell Disease Market Drivers
- 11.2 Gene Therapy for Sickle Cell Disease Market Restraints
- 11.3 Gene Therapy for Sickle Cell Disease Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Gene Therapy for Sickle Cell Disease Industry Chain
- 12.2 Gene Therapy for Sickle Cell Disease Upstream Analysis
- 12.3 Gene Therapy for Sickle Cell Disease Midstream Analysis
- 12.4 Gene Therapy for Sickle Cell Disease Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Gene Therapy for Sickle Cell Disease. Industry analysis & Market Report on Gene Therapy for Sickle Cell Disease is a syndicated market report, published as Global Gene Therapy for Sickle Cell Disease Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Gene Therapy for Sickle Cell Disease market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
